Personensuche
Personensuche
Es wurde 1 Person gefunden.
E-Mail
Funktionen
-
Wiss. Mitarbeiterinnen/Mitarbeiter, Klinik für Nuklearmedizin
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Demonstration of the Early Cardiac Bioavailability of a Non-Specific Cell-Targeted Peptide Using Radionuclide-Based Imaging In VivoIn: Pharmaceuticals, Jg. 16, 2023, Nr. 6, 824DOI, Online Volltext (Open Access)
-
PET/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the “Cancer Integrin” αvβ6 with Ga-68-TrivehexinIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2022, S. 1136 – 1147DOI (Open Access)
-
Gender-specific efficacy revealed by head-to-head comparison of pasireotide and octreotide in a representative in vivo model of nonfunctioning pituitary tumorsIn: Cancers, Jg. 13, 2021, Nr. 12, 3097DOI (Open Access)
-
It’s time to shift the paradigm : Translation and clinical application of non‐αvβ3 integrin targeting radiopharmaceuticalsIn: Cancers, Jg. 13, 2021, Nr. 23, 5958DOI (Open Access)
-
NIR fluorescence imaging of colon cancer with cRGD-ZW800-1 : Letter to the editorIn: Clinical Cancer Research, Jg. 27, 2021, Nr. 17, S. 4937DOI (Open Access)
-
PET/CT imaging of pancreatic carcinoma targeting the “cancer integrin” αvβ6In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 48, 2021, Nr. 12, S. 4107 – 4108DOI (Open Access)
-
PSMA PET Imaging in Glioblastoma : A Preclinical Evaluation and Theranostic OutlookIn: Frontiers in Oncology, Jg. 11, 2021, 774017DOI (Open Access)
-
PSMA-Targeted therapeutics : A tale about law and economicsIn: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 10, S. 1482 – 1482DOI (Open Access)
-
There is a world beyond αvβ3-integrin : Multimeric ligands for imaging of the integrin subtypes αvβ6, αvβ8, αvβ3, and α5β1 by positron emission tomographyIn: EJNMMI Research, Jg. 11, 2021, Nr. 1, 106DOI, Online Volltext (Open Access)
-
Towards ²¹³Bi alpha-therapeutics and beyond : Unravelling the foundations of efficient BiIIIcomplexation by DOTPIn: Inorganic Chemistry Frontiers: An International Journal of Inorganic Chemistry, Jg. 8, 2021, Nr. 16, S. 3893 – 3904
-
Al(iii)-NTA-fluoride : A simple model system for Al-F binding with interesting thermodynamicsIn: Dalton Transactions, Jg. 49, 2020, Nr. 39, S. 13726 – 13736
-
Click-Chemistry (CuAAC) Trimerization of an αvβ₆ Integrin Targeting Ga-68-Peptide : Enhanced Contrast for in-Vivo PET Imaging of Human Lung Adenocarcinoma XenograftsIn: ChemBioChem, Jg. 21, 2020, Nr. 19, S. 2836 – 2843DOI (Open Access)
-
First-Generation Bispidine Chelators for ²¹³BiIII Radiopharmaceutical ApplicationsIn: ChemMedChem, Jg. 15, 2020, Nr. 16, S. 1591 – 1600DOI (Open Access)
-
Tracking a TGF-β activator in vivo : Sensitive PET imaging of αvβ8-integrin with the Ga-68-labeled cyclic RGD octapeptide trimer Ga-68-TriveoctinIn: EJNMMI Research, Jg. 10, 2020, Nr. 1, 133DOI (Open Access)
-
In vivo imaging of early stages of rheumatoid arthritis by α5β1-integrin-targeted positron emission tomographyIn: EJNMMI Research, Jg. 9, 2019, Nr. 1, 87DOI (Open Access)
-
PIDAZTA : Structurally Constrained Chelators for the Efficient Formation of Stable Gallium-68 Complexes at Physiological pHIn: Chemistry - A European Journal, Jg. 25, 2019, Nr. 45, S. 10698 – 10709
-
Selective Targeting of Integrin αvβ8 by a Highly Active Cyclic PeptideIn: Journal of Medicinal Chemistry, Jg. 62, 2019, Nr. 4, S. 2024 – 2037
-
Synthesis and preclinical characterization of the PSMA-targeted hybrid tracer PSMA-I&F for nuclear and fluorescence imaging of prostate cancerIn: Journal of Nuclear Medicine (JNM), Jg. 60, 2019, Nr. 1, S. 71 – 78DOI (Open Access)
-
Dual-Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in RadiotherapyIn: Chemistry - A European Journal, Jg. 24, 2018, Nr. 3, S. 547 – 550DOI (Open Access)
-
Efficient formation of inert Bi-213 chelates by tetraphosphorus acid analogues of DOTA : Towards improved alpha-therapeuticsIn: EJNMMI Research, Jg. 8, 2018, 78DOI (Open Access)
-
Equilibrium thermodynamics, formation, and dissociation kinetics of Trivalent Iron and gallium complexes of triazacyclononane-triphosphinate (TRAP) chelators : Unraveling the foundations of highly selective Ga-68 labelingIn: Frontiers in Chemistry, Jg. 6, 2018, 170DOI (Open Access)
-
From a Helix to a Small Cycle : Metadynamics-Inspired αvβ6 Integrin Selective LigandsIn: Angewandte Chemie International Edition, Jg. 57, 2018, Nr. 44, S. 14645 – 14649
-
Lanthanide(iii) complexes of monophosphinate/monophosphonate DOTA-analogues : Effects of the substituents on the formation rate and radiolabelling yieldIn: Dalton Transactions, Jg. 47, 2018, Nr. 37, S. 13006 – 13015
-
Molar Activity of Ga-68 Labeled PSMA Inhibitor Conjugates Determines PET Imaging ResultsIn: Molecular Pharmaceutics, Jg. 15, 2018, Nr. 9, S. 4296 – 4302
-
N-Methylation of isoDGR Peptides : Discovery of a Selective α5β1-Integrin Ligand as a Potent Tumor Imaging AgentIn: Journal of Medicinal Chemistry, Jg. 61, 2018, Nr. 6, S. 2490 – 2499
-
Re-thinking the role of radiometal isotopes : Towards a future concept for theranostic radiopharmaceuticalsIn: Journal of Labelled Compounds and Radiopharmaceuticals, Jg. 61, 2018, Nr. 3, S. 141 – 153
-
Synthesis of symmetrical tetrameric conjugates of the radiolanthanide chelator DOTPI for application in endoradiotherapy by means of click chemistryIn: Frontiers in Chemistry, Jg. 6, 2018, 107DOI (Open Access)
-
Therapeutic Radiopharmaceuticals Targeting Integrin αvβ6In: ACS Omega, Jg. 3, 2018, Nr. 2, S. 2428 – 2436DOI (Open Access)
-
Correction to: In vivo imaging of early stages of rheumatoid arthritis by α5β1-integrin-targeted positron emission tomographyIn: EJNMMI Research. Berlin: Springer, Jg. 9, 2019, Nr. 1, 107DOI (Open Access)
-
Behind the scenes of Ga-68-Trivehexin development : Unique structure-activity relationshipsIn: Nuclear Medicine and Biology. New York; Oxford [u.a.]; New York, NY: Elsevier, Jg. 108, 2022, Nr. Supplement, S. 208 – S209